Azelastine reduces histamine-lnduced swelling of nasal mucosa

ORL

Volumn 58, Issue 3, 1996, Pages 157-163

  Spaeth, Joachim ^a   Schultze, Verena ^a   Klimek, Ludger ^b   Lengersdorf, Alf ^a   Mösges, Ralph ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Acoustic rhinometry; Allergic rhinitis; Anti obstructive effect; Azelastine nasal spray; Rhinomanometry; Symptom score

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; AZELASTINE; HISTAMINE;

ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; INTRANASAL DRUG ADMINISTRATION; NOSE CAVITY; NOSE MUCOSA; NOSE OBSTRUCTION; NOSE SECRETION; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RHINOMANOMETRY; SYMPTOM;

CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; LIPOXYGENASE INHIBITORS; NASAL OBSTRUCTION; NASAL PROVOCATION TESTS; NEBULIZERS AND VAPORIZERS; PHTHALAZINES; PLACEBOS; RANDOM ALLOCATION; RHINITIS, ALLERGIC, SEASONAL;

EID: 0029887135     PISSN: 03011569     EISSN: 14230275     Source Type: Journal    
DOI: 10.1159/000276817     Document Type: Article

References (17)

1. Bachert C, Colberg C: An update on drug therapy for allergic rhinitis. HNO 1990;38:1-6.
2. Gastpar H, Aurich R, Petzold U, Vimkaes C: Azelastine nasal spray for topical treatment of allergic rhinopathy. Atcmwcgs- Lungcncrkr 1993:19:1-6.
3. Dechant KL, Goa KL: Levocabastine: A review of its pharmacological properties and therapeutical potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs 1991; 41:202-224.
4. Spaeth J, Mösges R, Klimek L: Non-sedating antihistamines - fact or fiction? Allergologie 1994:17:204-207.
5. Mösges R, Kurzeja A, Schlöndorff G: Zum Stellenwert topischer Antihistaminika bei der Therapie der allergischen Rhinitis; in Mösges R, Schlöndorff G (Hrsg): Topische Therapie der allergischen Rhinitis. Zülpich, Biermann, 1993.
6. Kunkel G: Comparison of azclastinc versus new H 1-blockers (terfenadine. astemizolc). 15th Eur Congr Allergol Clin Immunol. Paris. 1992.
7. Horak F, Jäger S, Toth J, Berger U, Nimberger E: Azelastine in pollen-induced allergic rhinitis: A pharmacodynamic study of onset of action and efficacy. Drug Invest 1994:7:34-40.
8. Thomas KE, Oilier S, Ferguson H, Davies RJ: The effect of intranasal azelastine on nasal airway obstruction following provocation testing with histamine and allergen. Clin Exp Allergy 1992:22:642-647.
9. Dorow P, Aurich R, Petzold U: Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared with placebo and budesonide. Arzneimittclforschung/Drug Res 1993:43:909-912.
10. Bachmann W, Bachert C: Der Nasaltcst: in Fuchs E, Schulz K-H (Hrsg): Manuale allergo-logicum. München Deisenhofen, Dustri-Verlag Dr. Karl Feistle. 1987.
11. Hilbcrg O, Jackson AC, Swift DL, Pedersen OF: Acoustic rhinomctry: Evaluation of nasal cavity geometry by acoustic reflection. J Appl Physiol 1989;66:295-303.
12. Clement PAR: Committee report on standardization of rhinomanometry. Rhinology 1984: 22:151.
13. Vogt K, Sachse D, Wernecke K-D, Kriesmer T: Computerized rhinological diagnosis. HNO 1990:38:110-115.
14. Lenders H, Scholl R, Brunner M: Acoustic rhinomctry: The bat principle in the nose. HNO 1992 40:239-247.
15. Lenders H, Gall H: The nasal provocation test: A comparison between anterior rhinomanometry' and acoustic rhinometry. Allergologie 1992; 15:233-239.
16. Spaeth J, Mösges R, Lamprecht J: The clinical relevance of nasal provocation. Eur Arch Oto-rhinolaryngol Suppl 1993:2:352.
17. Spaeth J, Mösges R, Klimek L: Rhinometric -Rhinomanometrie - Symptomscores: Wie geeignet sind objektivierbare Parameter bei der Beurteilung der Symptomatik des allergischen Rhinitikcrs? In Mösges R. Schlöndorff G (Hrsg): Topische Therapie der allergischen Rhinitis. Zülpich. Biermann. 1993.